XML 52 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation Expense
Pre-tax share-based compensation expense reported in the Company’s consolidated statements of operations was:
 
Year Ended December 31,
 
2018
 
2017
 
2016
 
(in thousands)
Cost of sales
$
362

 
$
379

 
$
488

Selling, general and administrative expenses
12,743

 
9,394

 
10,199

Total share-based compensation expense
$
13,105

 
$
9,773

 
$
10,687

Stock Option Activity
Stock option activity during the year ended December 31, 2018 was:
 
Shares
 
Weighted Average Exercise Price
 
Weighted Average Contractual Life (Years)
 
Aggregate Intrinsic Value
 
(in thousands, except exercise price and years)
Outstanding as of December 31, 2017
541

 
$
11.00

 
5.37
 
$
1,918

Granted

 

 
 
 
 
Exercised
(152
)
 
8.36

 
 
 
 
Forfeited or expired
(27
)
 
25.09

 
 
 
 
Outstanding as of December 31, 2018
362

 
$
11.05

 
5.68
 
$
5,407

Exercisable at December 31, 2018
226

 
$
13.40

 
4.08
 
$
2,846

Vested and expected to vest at December 31, 2018
362

 
$
11.05

 
5.68
 
$
5,407

Schedule of Pricing Model Assumptions
During the year ended December 31, 2017, stock options were valued using a Black Scholes option pricing model using the following assumptions.
 
Year Ended December 31, 2017
Expected volatility
40.7%
Dividend yield
Risk-free interest rate
1.76%
Expected life (in years)
4.0
Schedule Of Restricted Stock Award And Restricted Stock Unit Activity
RSA and RSU activity during the year ended December 31, 2018 was:
 
Restricted Stock Awards (1)
 
Restricted Stock Units
 
Shares
 
Weighted Average Grant Date Fair Value
 
Shares
 
Weighted Average Grant Date Fair Value
 
(in thousands, except fair value data)
Unvested at December 31, 2017
17

 
$
6.84

 
3,791

 
$
7.99

Granted
13

 
18.61

 
1,404

 
14.34

Vested
(24
)
 
10.09

 
(1,123
)
 
8.60

Forfeited

 

 
(1,320
)
 
7.67

Unvested at December 31, 2018
6

 
$
18.61

 
2,752

 
$
11.58


(1) Excludes shares granted to members of the Board for annual equity awards.